MedicaidPrior AuthMedium impact
KMAP BULLETIN: Preferred Drug List Update
Kansas Medicaid (KanCare)·KS · Ophthalmology, Rheumatology, Endocrinology +1 more·Pharmacy
Effective date
Jan 1, 2024
We identified it
Jun 21, 2026
Summary
KMAP updated their Preferred Drug List effective January 1, 2024, requiring prior authorization for three new medications (Latanoprost, Secukinumab, and Insulin aspart) and removing prior auth requirements for Nadolol. This affects Kansas Medicaid patients and requires billing team updates to prevent claim denials.
Action Required
Immediately: Billing team must update prior authorization requirements in system for Kansas Medicaid patients. Add prior auth requirement for Latanoprost (IYUZEH) ophth solution, Secukinumab (Cosentyx UnoReady) pen, and Insulin aspart (Fiasp PumpCart) cartridge. Remove prior auth requirement for Nadolol (Corgard). Update encounter forms to alert providers. Monitor KanCare MCO implementation dates as they may vary from January 1, 2024 effective date.